Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk
Malcolm C. Pike, Darcy V. Spicer, Laila Dahmoush, and Michael F. Press
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Oncology..Incidence and Mortality of Breast Cancer
- Oncology..Epidemiology, Causes, and Risk Factors of Breast Cancer
- Medicine..Breast Issues
- Oncology..Epidemiology
- Medicine..Menopause
- Oncology..Environmental/Lifestyle Causes of Breast Cancer
- Oncology..Diet and Nutrition
- Oncology..Breast Cancer
- Oncology..Medroxyprogesterone
- Oncology..Incidence
- Oncology..Hormonal Causes of Cancer
- Oncology..Treatment Options for Breast Cancer
- Physiology..Estradiol
- Medicine..Progesterone
- Medicine..Obesity
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. P. Lydon and D. P. Edwards Finally! A Model for Progesterone Receptor Action in Normal Human Breast Endocrinology, July 1, 2009; 150(7): 2988 - 2990. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Graham, P. A. Mote, U. Salagame, J. H. van Dijk, R. L. Balleine, L. I. Huschtscha, R. R. Reddel, and C. L. Clarke DNA Replication Licensing and Progenitor Numbers Are Increased by Progesterone in Normal Human Breast Endocrinology, July 1, 2009; 150(7): 3318 - 3326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Glover, K. E. Gurley, K.-H. Kim, B. Storer, M. L. Fero, and C. J. Kemp Endocrine dysfunction in p27Kip1 deficient mice and susceptibility to Wnt-1 driven breast cancer Carcinogenesis, June 1, 2009; 30(6): 1058 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Phillips, R. C. Millikan, J. C. Schroeder, J. S. Barnholtz-Sloan, and B. J. Levine Reproductive and Hormonal Risk Factors for Ductal Carcinoma In situ of the Breast Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1507 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. N. Vandenberg, M. V. Maffini, C. Sonnenschein, B. S. Rubin, and A. M. Soto Bisphenol-A and the Great Divide: A Review of Controversies in the Field of Endocrine Disruption Endocr. Rev., February 1, 2009; 30(1): 75 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kim, S. K. Park, W. Han, D.-H. Kim, Y.-C. Hong, E. H. Ha, S.-H. Ahn, D.-Y. Noh, D. Kang, and K.-Y. Yoo Serum High-Density Lipoprotein Cholesterol and Breast Cancer Risk by Menopausal Status, Body Mass Index, and Hormonal Receptor in Korea Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Lee, Y. Zhu, K. M Govindasamy, and G. Gopalan Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells Endocr. Relat. Cancer, September 1, 2008; 15(3): 765 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Reding, J. R. Daling, D. R. Doody, C. A. O'Brien, P. L. Porter, and K. E. Malone Effect of Prediagnostic Alcohol Consumption on Survival after Breast Cancer in Young Women Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1988 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C M Friedenreich and A E Cust Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects Br. J. Sports Med., August 1, 2008; 42(8): 636 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Maruti, W. C. Willett, D. Feskanich, B. Rosner, and G. A. Colditz A Prospective Study of Age-Specific Physical Activity and Premenopausal Breast Cancer J Natl Cancer Inst, May 21, 2008; 100(10): 728 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Holmberg, O.-E. Iversen, C. M. Rudenstam, M. Hammar, E. Kumpulainen, J. Jaskiewicz, J. Jassem, D. Dobaczewska, H. E. Fjosne, O. Peralta, et al. Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors J Natl Cancer Inst, April 2, 2008; 100(7): 475 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Emaus, S. Espetvedt, M.B. Veierod, R. Ballard-Barbash, A.-S. Furberg, P.T. Ellison, G. Jasienska, A. Hjartaker, and I. Thune 17-{beta}-Estradiol in relation to age at menarche and adult obesity in premenopausal women Hum. Reprod., April 1, 2008; 23(4): 919 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-L. Lo, J.-C. Yu, S.-T. Chen, G.-C. Hsu, Y.-C. Mau, S.-L. Yang, P.-E. Wu, and C.-Y. Shen Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility Carcinogenesis, May 1, 2007; 28(5): 1079 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Tozlu, I Girault, S Vacher, J Vendrell, C Andrieu, F Spyratos, P Cohen, R Lidereau, and I Bieche Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach Endocr. Relat. Cancer, December 1, 2006; 13(4): 1109 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Eliassen, S. A. Missmer, S. S. Tworoger, D. Spiegelman, R. L. Barbieri, M. Dowsett, and S. E. Hankinson Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst, October 4, 2006; 98(19): 1406 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P Wiebe Progesterone metabolites in breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 717 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Perez-Palacios, R. Santillan, R. Garcia-Becerra, E. Borja-Cacho, F. Larrea, P. Damian-Matsumura, L. Gonzalez, and A. E Lemus Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern. J. Endocrinol., September 1, 2006; 190(3): 805 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Schaffer, C. M. Lachel, K. L. Pennington, C. R. Murrin, T. E. Strecker, M. Tochacek, K. A. Gould, J. L. Meza, R. D. McComb, and J. D. Shull Genetic Bases of Estrogen-Induced Tumorigenesis in the Rat: Mapping of Loci Controlling Susceptibility to Mammary Cancer in a Brown Norway x ACI Intercross. Cancer Res., August 1, 2006; 66(15): 7793 - 7800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rosenberg, J. R. Palmer, L. A. Wise, and L. L. Adams-Campbell A prospective study of female hormone use and breast cancer among black women. Arch Intern Med, April 10, 2006; 166(7): 760 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shen, D.-K. Li, J. Wu, Z. Zhang, and E. Gao Joint Effects of the CYP1A1 MspI, ER{alpha} PvuII, and ER{alpha} XbaI Polymorphisms on the Risk of Breast Cancer: Results from a Population-Based Case-Control Study in Shanghai, China. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 342 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Kaaks, S Rinaldi, T J Key, F Berrino, P H M Peeters, C Biessy, L Dossus, A Lukanova, S Bingham, K-T Khaw, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition Endocr. Relat. Cancer, December 1, 2005; 12(4): 1071 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Parodi Dairy Product Consumption and the Risk of Breast Cancer J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 556S - 568S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Collins, J. M. Blake, and P. G. Crosignani Breast cancer risk with postmenopausal hormonal treatment Hum. Reprod. Update, November 1, 2005; 11(6): 545 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Greendale, S. L. Palla, G. Ursin, G. A. Laughlin, C. Crandall, M. C. Pike, and B. A. Reboussin The Association of Endogenous Sex Steroids and Sex Steroid Binding Proteins with Mammographic Density: Results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study Am. J. Epidemiol., November 1, 2005; 162(9): 826 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S A Khan, D Bhandare, and R T Chatterton Jr The local hormonal environment and related biomarkers in the normal breast Endocr. Relat. Cancer, September 1, 2005; 12(3): 497 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Malin, C. E. Matthews, X.-O. Shu, H. Cai, Q. Dai, F. Jin, Y.-T. Gao, and W. Zheng Energy Balance and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1496 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kaaks, F. Berrino, T. Key, S. Rinaldi, L. Dossus, C. Biessy, G. Secreto, P. Amiano, S. Bingham, H. Boeing, et al. Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC) J Natl Cancer Inst, May 18, 2005; 97(10): 755 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J G Moggs, T C Murphy, F L Lim, D J Moore, R Stuckey, K Antrobus, I Kimber, and G Orphanides Anti-proliferative effect of estrogen in breast cancer cells that re-express ER{alpha} is mediated by aberrant regulation of cell cycle genes J. Mol. Endocrinol., April 1, 2005; 34(2): 535 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Tice, R. Miike, K. Adduci, N. L. Petrakis, E. King, and M. R. Wrensch Nipple Aspirate Fluid Cytology and the Gail Model for Breast Cancer Risk Assessment in a Screening Population Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 324 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Frech, E. D. Halama, M. T. Tilli, B. Singh, E. J. Gunther, L. A. Chodosh, J. A. Flaws, and P. A. Furth Deregulated Estrogen Receptor {alpha} Expression in Mammary Epithelial Cells of Transgenic Mice Results in the Development of Ductal Carcinoma In situ Cancer Res., February 1, 2005; 65(3): 681 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bardin, F. Moll, R. Margueron, C. Delfour, M. L. Chu, T. Maudelonde, V. Cavailles, and P. Pujol Transcriptional and Posttranscriptional Regulation of Fibulin-1 by Estrogens Leads to Differential Induction of Messenger Ribonucleic Acid Variants in Ovarian and Breast Cancer Cells Endocrinology, February 1, 2005; 146(2): 760 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Pearce, J. N. Hirschhorn, A. H. Wu, N. P. Burtt, D. O. Stram, S. Young, L. N. Kolonel, B. E. Henderson, D. Altshuler, and M. C. Pike Clarifying the PROGINS Allele Association in Ovarian and Breast Cancer Risk: A Haplotype-Based Analysis J Natl Cancer Inst, January 5, 2005; 97(1): 51 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Cui, M. Zhang, R. Pestell, E. M. Curran, W. V. Welshons, and S. A. W. Fuqua Phosphorylation of Estrogen Receptor {alpha} Blocks Its Acetylation and Regulates Estrogen Sensitivity Cancer Res., December 15, 2004; 64(24): 9199 - 9208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. MacInnis, D. R. English, D. M. Gertig, J. L. Hopper, and G. G. Giles Body Size and Composition and Risk of Postmenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2117 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Gould, M. Tochacek, B. S. Schaffer, T. M. Reindl, C. R. Murrin, C. M. Lachel, E. A. VanderWoude, K. L. Pennington, L. A. Flood, K. K. Bynote, et al. Genetic Determination of Susceptibility to Estrogen-Induced Mammary Cancer in the ACI Rat: Mapping of Emca1 and Emca2 to Chromosomes 5 and 18 Genetics, December 1, 2004; 168(4): 2113 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Ji, C. Aoyama, Y.-D. Nien, P. I. Liu, P. K. Chen, L. Chang, F. Z. Stanczyk, and A. Stolz Selective Loss of AKR1C1 and AKR1C2 in Breast Cancer and Their Potential Effect on Progesterone Signaling Cancer Res., October 15, 2004; 64(20): 7610 - 7617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Bardin, N Boulle, G Lazennec, F Vignon, and P Pujol Loss of ER{beta} expression as a common step in estrogen-dependent tumor progression Endocr. Relat. Cancer, September 1, 2004; 11(3): 537 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Brinton, B. Scoccia, K. S. Moghissi, C. L. Westhoff, M. D. Althuis, J. E. Mabie, and E. J. Lamb Breast cancer risk associated with ovulation-stimulating drugs Hum. Reprod., September 1, 2004; 19(9): 2005 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Anderson, K. C. Chu, S. Chang, and M. E. Sherman Comparison of Age-Specific Incidence Rate Patterns for Different Histopathologic Types of Breast Carcinoma Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1128 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Spychala, E. Lazarowski, A. Ostapkowicz, L. H. Ayscue, A. Jin, and B. S. Mitchell Role of Estrogen Receptor in the Regulation of Ecto-5'-Nucleotidase and Adenosine in Breast Cancer Clin. Cancer Res., January 15, 2004; 10(2): 708 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Korean Breast Cancer Society Clinical Characteristics of Breast Cancer Patients in Korea in 2000 Arch Surg, January 1, 2004; 139(1): 27 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vissac-Sabatier, V. Coxam, P. Dechelotte, C. Picherit, M.-N. Horcajada, M.-J. Davicco, P. Lebecque, Y.-J. Bignon, and D. Bernard-Gallon Phytoestrogen-Rich Diets Modulate Expression of Brca1 and Brca2 Tumor Suppressor Genes in Mammary Glands of Female Wistar Rats Cancer Res., October 15, 2003; 63(20): 6607 - 6612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cotterchio, N. Kreiger, B. Theis, M. Sloan, and S. Bahl Hormonal Factors and the Risk of Breast Cancer According to Estrogen- and Progesterone-Receptor Subgroup Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1053 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. Anderson, K. C. Chu, and S. Chang Inflammatory Breast Carcinoma and Noninflammatory Locally Advanced Breast Carcinoma: Distinct Clinicopathologic Entities? J. Clin. Oncol., June 15, 2003; 21(12): 2254 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. El-Rayes, S. Ali, L. K. Heilbrun, S. Lababidi, D. Bouwman, D. Visscher, and P. A. Philip Cytochrome P450 and Glutathione Transferase Expression in Human Breast Cancer Clin. Cancer Res., May 1, 2003; 9(5): 1705 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Byrne, P. M. Webb, T. W. Jacobs, G. Peiro, S. J. Schnitt, J. L. Connolly, W. C. Willett, and G. A. Colditz Alcohol Consumption and Incidence of Benign Breast Disease Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1369 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kumle, E. Weiderpass, T. Braaten, I. Persson, H.-O. Adami, and E. Lund Use of Oral Contraceptives and Breast Cancer Risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1375 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Okasha, P McCarron, J McEwen, and G D. Smith Body mass index in young adulthood and cancer mortality: a retrospective cohort study J Epidemiol Community Health, October 1, 2002; 56(10): 780 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Britton, M. D. Gammon, J. B. Schoenberg, J. L. Stanford, R. J. Coates, C. A. Swanson, N. Potischman, K. E. Malone, D. J. Brogan, J. R. Daling, et al. Risk of Breast Cancer Classified by Joint Estrogen Receptor and Progesterone Receptor Status among Women 20-44 Years of Age Am. J. Epidemiol., September 15, 2002; 156(6): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Wu, F. Z. Stanczyk, A. Seow, H.-P. Lee, and M. C. Yu Soy Intake and Other Lifestyle Determinants of Serum Estrogen Levels among Postmenopausal Chinese Women in Singapore Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 844 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Mink, E. Shahar, W. D. Rosamond, A. J. Alberg, and A. R. Folsom Serum Insulin and Glucose Levels and Breast Cancer Incidence: The Atherosclerosis Risk in Communities Study Am. J. Epidemiol., August 15, 2002; 156(4): 349 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Gammon, M. S. Wolff, A. I. Neugut, S. M. Eng, S. L. Teitelbaum, J. A. Britton, M. B. Terry, B. Levin, S. D. Stellman, G. C. Kabat, et al. Environmental Toxins and Breast Cancer on Long Island. II. Organochlorine Compound Levels in Blood Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 686 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Forsti, Q. Jin, E. Grzybowska, M. Soderberg, H. Zientek, M. Sieminska, J. Rogozinska-Szczepka, E. Chmielik, B. Utracka-Hutka, and K. Hemminki Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer Carcinogenesis, August 1, 2002; 23(8): 1315 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Fletcher and G. A. Colditz Failure of Estrogen Plus Progestin Therapy for Prevention JAMA, July 17, 2002; 288(3): 366 - 368. [Full Text] [PDF]
|
|
|
|
|
|
B. S. Han, K. Fukamachi, N. Takasuka, T. Ohnishi, M. Maeda, T. Yamasaki, and H. Tsuda Inhibitory effects of 17{beta}-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats Carcinogenesis, July 1, 2002; 23(7): 1209 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Love, N. B. Duc, N. V. Dinh, T.-Z. Shen, T. C. Havighurst, D. C. Allred, and D. L. DeMets Mastectomy and Oophorectomy by Menstrual Cycle Phase in Women With Operable Breast Cancer J Natl Cancer Inst, May 1, 2002; 94(9): 662 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Hewitt, W. P. Bocchinfuso, J. Zhai, C. Harrell, L. Koonce, J. Clark, P. Myers, and K. S. Korach Lack of Ductal Development in the Absence of Functional Estrogen Receptor {alpha} Delays Mammary Tumor Formation Induced by Transgenic Expression of ErbB2/neu Cancer Res., May 1, 2002; 62(10): 2798 - 2805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Endogenous Hormones and Breast Cancer Collabor Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies J Natl Cancer Inst, April 17, 2002; 94(8): 606 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Peck, B. S. Hulka, C. Poole, D. A. Savitz, D. Baird, and B. E. Richardson Steroid Hormone Levels during Pregnancy and Incidence of Maternal Breast Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 361 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Chen, N. S. Weiss, P. Newcomb, W. Barlow, and E. White Hormone Replacement Therapy in Relation to Breast Cancer JAMA, February 13, 2002; 287(6): 734 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M.E Harvell, T. E. Strecker, B. Xie, K. L. Pennington, R. D. McComb, and J. D. Shull Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat Carcinogenesis, January 1, 2002; 23(1): 161 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Q. Ma, Z. Liu, E. S. W. Ngan, and S. Y. Tsai Cdc25B Functions as a Novel Coactivator for the Steroid Receptors Mol. Cell. Biol., December 1, 2001; 21(23): 8056 - 8067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Shull, K. L. Pennington, T. M. Reindl, M. C. Snyder, T. E. Strecker, T. J. Spady, M. Tochacek, and R. D. McComb Susceptibility to Estrogen-Induced Mammary Cancer Segregates as an Incompletely Dominant Phenotype in Reciprocal Crosses between the ACI and Copenhagen Rat Strains Endocrinology, December 1, 2001; 142(12): 5124 - 5130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gadd, C. Pisc, J. Branda, V. Ionescu-Tiba, Z. Nikolic, C. Yang, T. Wang, G. M. Shackleford, R. D. Cardiff, and E. V. Schmidt Regulation of Cyclin D1 and p16INK4A Is Critical for Growth Arrest during Mammary Involution Cancer Res., December 1, 2001; 61(24): 8811 - 8819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Okamoto, R. Horisawa, T. Kawamura, A. Asai, M. Ogino, T. Takagi, and Y. Ohno Menstrual and Reproductive Factors for Subarachnoid Hemorrhage Risk in Women: A Case-Control Study in Nagoya, Japan Stroke, December 1, 2001; 32(12): 2841 - 2844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. E. Harvell, T. E. Strecker, B. Xie, L. K. Buckles, M. Tochacek, R. D. McComb, and J. D. Shull Diet-Gene Interactions in Estrogen-Induced Mammary Carcinogenesis in the ACI Rat J. Nutr., November 1, 2001; 131(11): 3087S - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rajkumar, R. C. Guzman, J. Yang, G. Thordarson, F. Talamantes, and S. Nandi Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis PNAS, September 25, 2001; 98(20): 11755 - 11759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Mills, A. J. Lee, A. F. Parlow, and B. T. Zhu Preferential Growth Stimulation of Mammary Glands over Uterine Endometrium in Female Rats by a Naturally Occurring Estradiol-17{beta}-fatty Acid Ester Cancer Res., August 1, 2001; 61(15): 5764 - 5770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-J. W. Lu, K. E. Anderson, J. J. Grady, and M. Nagamani Effects of an Isoflavone-Free Soy Diet on Ovarian Hormones in Premenopausal Women J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3045 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Marcantonio, L. E. Chalifour, M. A. Alaoui-Jamali, L. Alpert, and H. T. Huynh Cloning and Characterization of a Novel Gene That Is Regulated by Estrogen and Is Associated with Mammary Gland Carcinogenesis Endocrinology, June 1, 2001; 142(6): 2409 - 2418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Newcomb, A. Trentham-Dietz, K. M. Egan, L. Titus-Ernstoff, J. A. Baron, B. E. Storer, W. C. Willett, and M. J. Stampfer Fracture History and Risk of Breast and Endometrial Cancer Am. J. Epidemiol., June 1, 2001; 153(11): 1071 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. O'Meara, M. A. Rossing, J. R. Daling, J. G. Elmore, W. E. Barlow, and N. S. Weiss Hormone Replacement Therapy After a Diagnosis of Breast Cancer in Relation to Recurrence and Mortality J Natl Cancer Inst, May 16, 2001; 93(10): 754 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ursin, Y. R. Parisky, M. C. Pike, and D. V. Spicer Mammographic Density Changes During the Menstrual Cycle Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 141 - 142. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Clemons and P. Goss Estrogen and the Risk of Breast Cancer N. Engl. J. Med., January 25, 2001; 344(4): 276 - 285. [Full Text] [PDF]
|
|
|
|
|
|
P. H. Gann, S. Giovanazzi, L. Van Horn, A. Branning, and R. T. Chatterton Jr. Saliva as a Medium for Investigating Intra- and Interindividual Differences in Sex Hormone Levels in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., January 1, 2001; 10(1): 59 - 64. [Abstract] [Full Text]
|
|
|
|
|
|
K. Innes, T. Byers, and M. Schymura Birth Characteristics and Subsequent Risk for Breast Cancer in Very Young Women Am. J. Epidemiol., December 15, 2000; 152(12): 1121 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Colditz and B. Rosner Cumulative Risk of Breast Cancer to Age 70 Years According to Risk Factor Status: Data from the Nurses' Health Study Am. J. Epidemiol., November 15, 2000; 152(10): 950 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A Wiseman Breast cancer hypothesis: a single cause for the majority of cases J Epidemiol Community Health, November 1, 2000; 54(11): 851 - 858. [Abstract] [Full Text]
|
|
|
|
|
|
A. H. Charpentier, A. K. Bednarek, R. L. Daniel, K. A. Hawkins, K. J. Laflin, S. Gaddis, M. C. MacLeod, and C. M. Aldaz Effects of Estrogen on Global Gene Expression: Identification of Novel Targets of Estrogen Action Cancer Res., November 1, 2000; 60(21): 5977 - 5983. [Abstract] [Full Text]
|
|
|
|
|
|
X. Chen, C. Danes, M. Lowe, T. W. Herliczek, and K. Keyomarsi Activation of the Estrogen-Signaling Pathway by p21WAF1/CIP1 in Estrogen Receptor-Negative Breast Cancer Cells J Natl Cancer Inst, September 6, 2000; 92(17): 1403 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Brisson, B. Brisson, G. Coté, E. Maunsell, S. Bérubé, and J. Robert Tamoxifen and Mammographic Breast Densities Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 911 - 915. [Abstract] [Full Text]
|
|
|
|
|
|
L.-J. W. Lu, K. E. Anderson, J. J. Grady, F. Kohen, and M. Nagamani Decreased Ovarian Hormones during a Soya Diet: Implications for Breast Cancer Prevention Cancer Res., August 1, 2000; 60(15): 4112 - 4121. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Russo, Y.-F. Hu, X. Yang, and I. H. Russo Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 17 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Thompson and C. Ambrosone Chapter 7: Molecular Epidemiology of Genetic Polymorphisms in Estrogen Metabolizing Enzymes in Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 125 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Fears, R. G. Ziegler, J. L. Donaldson, R. T. Falk, R. N. Hoover, F. Z. Stanczyk, J. B. Vaught, and M. H. Gail Reproducibility Studies and Interlaboratory Concordance for Androgen Assays in Female Plasma Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 403 - 412. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Stoica, B. S. Katzenellenbogen, and M. B. Martin Activation of Estrogen Receptor-{alpha} by the Heavy Metal Cadmium Mol. Endocrinol., April 1, 2000; 14(4): 545 - 553. [Abstract] [Full Text]
|
|
|
|
 |
|
 N Andrieu, T Prevost, T. Rohan, E Luporsi, M. Le, M Gerber, D. Zaridze, Y Lifanova, R Renaud, H. Lee, et al. Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality Int. J. Epidemiol., April 1, 2000; 29(2): 214 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-J. W. Lu, M. Cree, S. Josyula, M. Nagamani, J. J. Grady, and K. E. Anderson Increased Urinary Excretion of 2-Hydroxyestrone but not 16{{alpha}}-Hydroxyestrone in Premenopausal Women during a Soya Diet Containing Isoflavones Cancer Res., March 1, 2000; 60(5): 1299 - 1305. [Abstract] [Full Text]
|
|
|
|
|
|
R. K. Ross, A. Paganini-Hill, P. C. Wan, and M. C. Pike Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin J Natl Cancer Inst, February 16, 2000; 92(4): 328 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Wiebe, D. Muzia, J. Hu, D. Szwajcer, S. A. Hill, and J. L. Seachrist The 4-Pregnene and 5{{alpha}}-Pregnane Progesterone Metabolites Formed in Nontumorous and Tumorous Breast Tissue Have Opposite Effects on Breast Cell Proliferation and Adhesion Cancer Res., February 1, 2000; 60(4): 936 - 943. [Abstract] [Full Text]
|
|
|
|
|
|
C. S. Healey, A. M. Dunning, F. Durocher, D. Teare, P. D.P. Pharoah, R. N. Luben, D. F. Easton, and B. A.J. Ponder Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk Carcinogenesis, February 1, 2000; 21(2): 189 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gardner, G. Belka, G. Wertheim, J. Hartman, S. Ha, P. Gimotty, S. Marquis, and L. Chodosh Developmental role of the SNF1-related kinase Hunk in pregnancy-induced changes in the mammary gland Development, January 10, 2000; 127(20): 4493 - 4509. [Abstract] [PDF]
|
|
|
|
|
|
K. J. Aronson, A. B. Miller, C. G. Woolcott, E. E. Sterns, D. R. McCready, L. A. Lickley, E. B. Fish, G. Y. Hiraki, C. Holloway, T. Ross, et al. Breast Adipose Tissue Concentrations of Polychlorinated Biphenyls and Other Organochlorines and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 55 - 63. [Abstract] [Full Text]
|
|
|
|
|
|
Hormone Replacement Therapy with Estrogen or Estrogen plus Medroxyprogesterone Acetate Is Associated with Increased Epithelial Proliferation in the Normal Postmenopausal Breast J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4559 - 4565. [Abstract] [Full Text]
|
|
|
|
|
|
S. A. Khan, A. Sachdeva, S. Naim, M. M. Meguid, W. Marx, H. Simon, J. D. Halverson, and P. J. Numann The Normal Breast Epithelium of Women with Breast Cancer Displays an Aberrant Response to Estradiol Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 867 - 872. [Abstract] [Full Text]
|
|
|
|
|
|
C.-S. Huang, H.-D. Chern, K.-J. Chang, C.-W. Cheng, S.-M. Hsu, and C.-Y. Shen Breast Cancer Risk Associated with Genotype Polymorphism of the Estrogen-metabolizing Genes CYP17, CYP1A1, and COMT: A Multigenic Study on Cancer Susceptibility Cancer Res., October 1, 1999; 59(19): 4870 - 4875. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||